BIO-key Implements Reverse Stock Split to Maintain Nasdaq Listing

The latest update is out from BIO-key International ( (BKYI) ).

On April 20, 2026, BIO-key stockholders approved an amendment to implement a reverse stock split of the company’s common stock, authorizing a ratio between 1-for-2 and 1-for-10, with the final terms left to the board’s discretion. Following this approval, the board set the ratio at 1-for-10, and a Certificate of Amendment filed in Delaware on April 28, 2026, will take effect at 5:00 p.m. Eastern on April 29, 2026, reducing outstanding shares from about 10.9 million to roughly 1.1 million, while leaving authorized shares and par value unchanged and rounding up any fractional shares.

The stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market under a new CUSIP on April 30, 2026, a move explicitly aimed at helping BIO-key regain compliance with Nasdaq’s minimum bid price requirement. Management framed the action as positioning the stock for continued listing as the company pursues its growth and profitability objectives into 2026, signaling to investors a focus on capital markets stability alongside its core cybersecurity and IAM operations.

The most recent analyst rating on (BKYI) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on BIO-key International stock, see the BKYI Stock Forecast page.

Spark’s Take on BKYI Stock

According to Spark, TipRanks’ AI Analyst, BKYI is a Neutral.

The score is primarily held down by weak financial performance—ongoing large losses and negative cash flow—along with bearish technicals (below major moving averages). Offsetting factors include improving operational narrative and upbeat near-term guidance from the earnings call, but execution and compliance/reporting risks remain notable.

To see Spark’s full report on BKYI stock, click here.

More about BIO-key International

BIO-key International, Inc. is a global provider of identity and access management and biometric authentication technologies, serving more than 40 million users. The company’s portfolio includes its PortalGuard IAM platform, offered as a cloud-hosted or on-premise solution that enables phoneless, tokenless and passwordless multi-factor authentication for secure access to systems, applications and high-value transactions.

Average Trading Volume: 366,834

Technical Sentiment Signal: Sell

Current Market Cap: $6.49M

For detailed information about BKYI stock, go to TipRanks’ Stock Analysis page.